Catalyst Wire Dossier Catalyst Wire Dossier

Flynpovi

eflornithine hydrochloride; sulindac · Cancer Prevention Pharma (Ireland) Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Flynpovi, covering 2021-12-07 to 2021-12-07. Get the full timeline:

Most recent: EMA Application withdrawn: Flynpovi (eflornithine hydrochloride;sulindac) — Cancer Prevention Pharma (Ireland) Limited

See pricing